Here are just a few editorial highlights from the DDNews Cancer Research News site and other online vehicles of DDNews magazine to get you acquainted with the website and show you the range of our coverage.
 

 
By Jeffrey Bouley, DDNews Chief Editor
Multiple Myeloma Research Foundation announces six new clinical trials in 2014, and Cellectar Biosciences announces IND for relapsed or refractory multiple myeloma drug
 
By Lloyd Dunlap, DDNews Managing Editor
With some tinkering, MIT chemists recruit anthrax to deliver anti-cancer drugs
 
Guest Commentary: Developing humanized cancer models for cost-effective and productive cancer drug discovery
By Dr. Jean-Pierre Wery, CrownBio
Oncology drug discovery faces one of the highest attrition rates for drug candidates in the development pipeline, largely due to efficacy issues. More relevant clinical models, ones that better reflect cancer heterogeneity and disease progression, could address this problem.
 
By Lloyd Dunlap, DDNews Managing Editor
FDA submission reinforces commitment to addressing significant unmet needs for patients with acute lymphoblastic leukemia, an aggressive cancer with limited treatment options
 
DDNews Cancer Research Exclusive: Turning an eye to TERT
By Kelsey Kaustinen, DDNews Senior Editor
As part of the TCGA initiative, researchers have discovered multiple cases of missing chromosomes in chromophobe renal cell carcinoma, as well as rearrangements in the promoter region of the TERT gene
 
 
 
 
 
Clinical Genomics Center established by Lab21, ITOR
April 2012
SHARING OPTIONS:

CAMBRIDGE, U.K.—Lab21 recently launched a new Clinical Genomics Center at the Greenville Hospital System (GHS) Memorial Medical Campus in Greenville, S.C. Located in the GHS Institute for Translational Oncology Research (ITOR), the new center continues an ongoing collaboration to introduce complex biomarker analysis into routine cancer patient management. A strategic relationship with Life Technologies, whose Ion Torrent Personal Genome Machine will serve as the key launch platform technology, led to the establishment of the facility.  
 
"Bringing this leading-edge technology to the cancer clinic represents a significant breakthrough and the culmination of a seven-year journey," Dr. Joe Stephenson, medical director for ITOR, noted in a statement. "This genomics center is another major step towards fulfilling our vision to provide personalized cancer care—better enabling us to offer the right drug, at the right time, to the right patient."

Back







CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2014 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.